In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes - PubMed (original) (raw)
In vitro and in vivo effects of 2-methoxyestradiol, either alone or combined with albendazole, against Echinococcus metacestodes
Martin Spicher et al. Exp Parasitol. 2008 Aug.
Abstract
The metacestode (larval) stage of the tapeworm Echinococcus multilocularis causes alveolar echinococcosis (AE), a mainly hepatic disease characterized by continuous asexual proliferation of metacestodes by exogenous budding, resulting in the tumor-like, infiltrative growth of the parasite lesion. Current chemotherapeutical treatment of AE relies on the use of benzimidazoles (albendazole, mebendazole), but these drugs act parasitostatic rather than parasitocidal, and in case of side effects such as liver toxicity, patients are left without valuable alternatives. 2-ME2 is a natural metabolite of estradiol, with a documented anti-angiogenic and broad spectrum anti-tumour activity. Treatments of in vitro cultured E. multilocularis metacestodes with 2-ME2 (2-10 microM) showed that the drug has an adverse effect on parasite viability. First, 2-ME in vitro treatment downscaled the transcription of the 14-3-3-pro-tumorogenic zeta-isoform in E. multilocularis metacestodes. Second, scanning and transmission electron microscopy showed that the germinal layer of E. multilocularis metacestodes was dramatically damaged following 2-ME2-treatment, and the effect was dose-dependent. Similar results were obtained with E. granulosus metacestodes. Bioassays were performed in mice injected with 2-ME2-treated and albendazole-treated metacestodes, or parasites-treated with both 2-ME and albendazole in combination. These assays indicated that, despite inducing considerable damage in vitro, neither of the drugs was capable of exerting a true parasiticidal effect, but best results were achieved with a combination of both compounds. In vivo treatment in E. multilocularis-infected mice for a period of 6 weeks showed that a combined 2-ME2/albendazole based treatment lead to a reduction in parasite weight, but the results did not show statistical difference from the application of albendazole alone.
Similar articles
- Efficacy of albendazole in combination with thymol against Echinococcus multilocularis protoscoleces and metacestodes.
María AC, Celina EM. María AC, et al. Acta Trop. 2014 Dec;140:61-7. doi: 10.1016/j.actatropica.2014.08.007. Epub 2014 Aug 19. Acta Trop. 2014. PMID: 25149355 - Activities of fenbendazole in comparison with albendazole against Echinococcus multilocularis metacestodes in vitro and in a murine infection model.
Küster T, Stadelmann B, Aeschbacher D, Hemphill A. Küster T, et al. Int J Antimicrob Agents. 2014 Apr;43(4):335-42. doi: 10.1016/j.ijantimicag.2014.01.013. Epub 2014 Feb 12. Int J Antimicrob Agents. 2014. PMID: 24646943 - In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis.
Küster T, Stadelmann B, Hermann C, Scholl S, Keiser J, Hemphill A. Küster T, et al. Antimicrob Agents Chemother. 2011 Feb;55(2):713-21. doi: 10.1128/AAC.01392-10. Epub 2010 Dec 6. Antimicrob Agents Chemother. 2011. PMID: 21135182 Free PMC article. - Treatment of echinococcosis: albendazole and mebendazole--what else?
Hemphill A, Stadelmann B, Rufener R, Spiliotis M, Boubaker G, Müller J, Müller N, Gorgas D, Gottstein B. Hemphill A, et al. Parasite. 2014;21:70. doi: 10.1051/parasite/2014073. Epub 2014 Dec 22. Parasite. 2014. PMID: 25526545 Free PMC article. Review. - Innovative chemotherapeutical treatment options for alveolar and cystic echinococcosis.
Hemphill A, Spicher M, Stadelmann B, Mueller J, Naguleswaran A, Gottstein B, Walker M. Hemphill A, et al. Parasitology. 2007 Nov;134(Pt 12):1657-70. doi: 10.1017/S0031182007003198. Epub 2007 Jul 16. Parasitology. 2007. PMID: 17631693 Review.
Cited by
- Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis.
Jiang H, Wang X, Guo L, Tan X, Gui X, Liao Z, Li Z, Chen X, Wu X. Jiang H, et al. Parasit Vectors. 2023 Nov 7;16(1):407. doi: 10.1186/s13071-023-05999-4. Parasit Vectors. 2023. PMID: 37936208 Free PMC article. - In Vitro and In Vivo Efficacy of DNA Damage Repair Inhibitor Veliparib in Combination with Artesunate against Echinococcus granulosus.
Li YF, Wen LM, Zhao J, Lv GD, Lu S, Lu S, Zheng X, Chen B, Tian CY, Gong YH, Gao HJ, Wang JH. Li YF, et al. Dis Markers. 2020 Jul 1;2020:8259820. doi: 10.1155/2020/8259820. eCollection 2020. Dis Markers. 2020. PMID: 32714467 Free PMC article. - Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
Lundström-Stadelmann B, Rufener R, Hemphill A. Lundström-Stadelmann B, et al. Int J Parasitol Drugs Drug Resist. 2020 Aug;13:121-129. doi: 10.1016/j.ijpddr.2020.06.002. Epub 2020 Jul 2. Int J Parasitol Drugs Drug Resist. 2020. PMID: 32636148 Free PMC article. - The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis.
Lundström-Stadelmann B, Rufener R, Ritler D, Zurbriggen R, Hemphill A. Lundström-Stadelmann B, et al. Food Waterborne Parasitol. 2019 Mar 14;15:e00040. doi: 10.1016/j.fawpar.2019.e00040. eCollection 2019 Jun. Food Waterborne Parasitol. 2019. PMID: 32095613 Free PMC article. - In vitro and in vivo effects of 3-bromopyruvate against Echinococcus metacestodes.
Xin Q, Yuan M, Li H, Song X, Lu J, Jing T. Xin Q, et al. Vet Res. 2019 Nov 19;50(1):96. doi: 10.1186/s13567-019-0710-7. Vet Res. 2019. PMID: 31744550 Free PMC article.